Clinical use of recombinant tissue plasminogen activator for anterior chamber fibrinolysis.
In a preliminary clinical study, 12.5 micrograms/100 microliters of recombinant tissue plasminogen activator (rt-PA) was injected into the anterior chamber of 3 eyes of 3 patients who suffered from excessive post-operative fibrin formation. The prominent fibrinolytic effect was achieved without any side effect. Rt-PA is an effective and safe regimen for the management of excessive post-operative intraocular fibrin formation.